4//SEC Filing
McLaughlin Mark 4
Accession 0001213900-18-002139
CIK 0000948320other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 8:00 PM ET
Size
28.2 KB
Accession
0001213900-18-002139
Insider Transaction Report
Form 4
Immudyne, Inc.IMMD
McLaughlin Mark
DirectorChief Executive Officer10% Owner
Transactions
- Disposition to Issuer
Common Stock, par value $0.01
2018-02-13$0.23/sh−1,130,436$260,000→ 2,640,507 total - Disposition to Issuer
Common Stock, par value $0.01
2018-02-13$0.23/sh−217,391$50,000→ 634,784 total(indirect: Faith McLaughlin - Daughter) - Sale
Common Stock, par value $0.01
2018-02-13$0.23/sh−298,407$68,634→ 2,342,100 total - Sale
Common Stock, par value $0.01
2018-02-13$0.23/sh−100,000$23,000→ 1,040,000 total(indirect: McLaughlin International, Inc.) - Sale
Common Stock, par value $0.01
2018-02-13$0.23/sh−190,000$43,700→ 54,228 total(indirect: By Spouse) - Disposition to Issuer
Common Stock, par value $0.01
2018-02-13$0.23/sh−217,391$50,000→ 512,284 total(indirect: Genevieve McLaughlin - Daughter) - Sale
Common Stock, par value $0.01
2018-02-13$0.23/sh−5,504$1,266→ 506,780 total(indirect: Genevieve McLaughlin - Daughter) - Disposition to Issuer
Common Stock, par value $0.01
2018-02-13$0.23/sh−217,391$50,000→ 553,284 total(indirect: James McLaughlin - Son) - Sale
Common Stock, par value $0.01
2018-02-13$0.23/sh−15,000$3,450→ 538,284 total(indirect: James McLaughlin - Son) - Sale
Common Stock, par value $0.01
2018-02-13$0.23/sh−31,504$7,246→ 506,780 total(indirect: James McLaughlin - Son) - Disposition to Issuer
Common Stock, par value $0.01
2018-02-13$0.23/sh−217,391$50,000→ 538,362 total(indirect: Mark McLaughlin Jr. - Son) - Sale
Common Stock, par value $0.01
2018-02-13$0.23/sh−31,582$7,264→ 506,780 total(indirect: Mark McLaughlin Jr. - Son) - Sale
Common Stock, par value $0.01
2018-02-13$0.23/sh−96,593$22,216→ 538,191 total(indirect: Faith McLaughlin - Daughter) - Sale
Common Stock, par value $0.01
2018-02-13$0.23/sh−31,410$7,224→ 506,781 total(indirect: Faith McLaughlin - Daughter)
Footnotes (5)
- [F1]As part of the consideration for the purchase of certain assets of Immudyne Inc. by the reporting person pursuant to the Legacy Assets Sale Agreement dated January 26, 2018, and amended on February 7, 2018, each as disclosed on Immudyne's Form 8-K filed on February 15, 2018, the reporting person and his affiliates agreed to return to Immudyne a total of 2,000,000 shares of its common stock valued at $0.23 per share.
- [F2]The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- [F3]The Reporting Persons beneficially owns shares through a company owned together with his spouse.
- [F4]These shares were sold in a private transaction to JOJ Holdings, Inc., an entity affiliated with Immudyne's President and Chief Executive Officer, Justin Schreiber, in connection with the transactions contemplated by the Legacy Assets Sale Agreement.
- [F5]These shares were sold in private transactions in connection with the transactions contemplated by the Legacy Assets Sale Agreement.
Documents
Issuer
Immudyne, Inc.
CIK 0000948320
Entity typeother
Related Parties
1- filerCIK 0001721526
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 8:00 PM ET
- Size
- 28.2 KB